González-Muñoza, C, Calafat, M, Gisbert, JP, Iglesias, E, Minguez, M, Sicilia, B, Aceituno, M, Gomollón, F, Calvet, X, Ricart, E, De Castro, L, Rivero, M, Mesonero, F, Márquez, L, Nos, P, Rodriguez-Pescador, A, Guardiola, J, García-Sepulcre, M, García-López, S, Lorente-Poyatos, RH, Alba, C, Sánchez-Ocaña, R, Vera, I, Madero, L, Riestra, S, Navarro-Llavat, M, Pérez-Calle, JL, Camps, B, Van Domselaar, M, Lucendo, AJ, Martin-Arranz, MD, Montoro-Huguet, MA, Sierra-Ausin, M, Llao, J, Carpio, D, Varela, P, Merino, O, Fernandez-Salazar, L, Piqueras, M, Sese, E, Busquets, D, Tardillo, C, Maroto, N, Riera, J, Martinez-Flores, C, Munoz, F, Gordillo-abalos, J, Bertoletti, F, Garcia-Planella, E, Domènech, E. Influence of familial forms of inflammatory bowel disease on the use of immunosuppressants, biological agents, and surgery in the era of biological therapies. Results from the ENEIDA project. POSTGRADUATE MEDICAL JOURNAL. 2024; DOI:10.1093/postmj/qgae076. PMID:38913019. IF:2.700(Q1/3D).

Guerra, I, Barros, F, Chaparro, M, Benítez, JM, Martín-Arranz, MD, de Francisco, R, Piqueras, M, de Castro, L, Carbajo, AY, Bermejo, F, Mínguez, M, Gutiérrez, A, Mesonero, F, Cañete, F, González-Muñoza, C, Calvo, M, Sicilia, B, Alfambra, E, Rivero, M, Lucendo, AJ, Tardillo, CA, Almela, P, Bujanda, L, van Domselaar, M, Ramos, L, Sánchez, MF, Hinojosa, E, Verdejo, C, Gimenez, A, Rodriguez-Lago, I, Manceñido, N, Calle, JLP, Moreno, MD, Delgado-Guillena, PG, Antolin, B, de la Piscina, PR, Casanova, MJ, Escribano, PS, Arranz, EM, Perez-Martínez, I, Mena, R, Morales, NG, Granja, A, Watts, MMB, Francés, R, Fernandez, C, Calafat, M, Roig-Ramos, C, Vera, MI, Carracedo, A, Domènech, E, Gisbert, JP. Evaluation of Genetic Variants Associated with the Risk of Thiopurine-Related Pancreatitis: A Case Control Study from ENEIDA Registry. DIGESTIVE DISEASES. 2024; 42(3)DOI:10.1159/000537782. PMID:38452742. IF:2.100(Q3/7D).

Gutiérrez-Rios, L, Calafat, M, Pascual, I, Roig, C, Teniente-Serra, A, Vergés, L, González-Muñoza, C, Vayreda, E, Vázquez, D, Gordillo, J, Mañosa, M, Ramírez, C, Garcia-Planella, E, Planella, M, Domènech, E. The Usefulness of Intraepithelial Lymphocyte Immunophenotype Testing for the Diagnosis of Coeliac Disease in Clinical Practice. Nutrients. 2024; 16(11)DOI:10.3390/nu16111633. PMID:38892566. IF:5.000(Q1/2D).

Torras, C, Bañares, J, Martí, A, Acin, V, Pagès, L, Gutiérrez, L, Casabella, A, Ferrusquía, JA, Sánchez, J, Pérez, M, Fuertes, D, Garcia, M, Soriano, G, Masnou, H, Amador, A, Cuyas, B, Pericàs, JM, Gasch, O, Solé, C. Comparison in epidemiologyand outcomes of bacterial infections in patients with cirrhosis between university hospitals with and without liver transplant. JOURNAL OF HEPATOLOGY. 2024; 80DOI:. PMID:. IF:33.000(Q1/1D).

Fernández, J, Núñez, L, Costa, M, Torres, M, Horrillo, R, Afonso, N, Mestre, A, Del Arbol, LR, Villanueva, C, Paez, A, Arroyo, V. Safety and tolerability of long-term albumin treatment in patients with decompensated cirrhosis. JOURNAL OF HEPATOLOGY. 2024; 80DOI:. PMID:. IF:33.000(Q1/1D).

Alberch, PO, Soler, A, Téllez, L, Carrión, JA, Alvarado-Tapias, E, Ferrusquía, JA, Lens, S, Guerrero, A, Falgà, MA, Vizcarra, P, Orts, L, Perez, V, Shalaby, S, Baiges, A, Turon, F, García-Pagán, JC, García-Criado, MA, Hernández-Gea, V. Evaluation of portal hemodynamics after etiological factor removal and persistence of varices in patients with an HVPG <10 mmHg and NITs within the grey zone. JOURNAL OF HEPATOLOGY. 2024; 80DOI:. PMID:. IF:33.000(Q1/1D).

Garcia, MJ, Riestra, S, Amiot, A, Julsgaard, M, de la Filia, IG, Calafat, M, Aguas, M, de la Pena, L, Roig, C, Caballol, B, Casanova, MJ, Farkas, K, Boysen, T, Bujanda, L, Cuaran, C, Dobru, D, Fousekis, F, Gargallo-Puyuelo, CJ, Savarino, E, Calvet, X, Huguet, JM, Kupcinskas, L, López-Cardona, J, Raine, T, van Oostrom, J, Gisbert, JP, Chaparro, M. Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study). ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2024; 59(10)DOI:10.1111/apt.17938. PMID:38445785. IF:6.700(Q1/1D).

Gómez-Labrador, C, Ricart, E, Iborra, M, Iglesias, E, Martín-Arranz, MD, de Castro, L, De Francisco, R, García-Alonso, FJ, Sanahuja, A, Gargallo-Puyuelo, CJ, Mesonero, F, Casanova, MJ, Mañosa, M, Rivero, M, Calvo, M, Sierra-Ausin, M, González-Muñoza, C, Calvet, X, García-López, S, Guardiola, J, García, LA, Márquez-Mosquera, L, Gutiérrez, A, Zabana, Y, Navarro-Llavat, M, Poyatos, RL, Piqueras, M, Torrealba, L, Bermejo, F, Ponferrada-Díaz, A, Pérez-Calle, JL, Barreiro-de Acosta, M, Tejido, C, Cabriada, JL, Marín-Jiménez, I, Roncero, O, Ber, Y, Fernández-Salazar, L, Aler, BC, Lucendo, AJ, Llaó, J, Bujanda, L, Villafranca, CM, Domènech, E, Chaparro, M, Gisbert, JP. Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA. Pharmaceutics. 2024; 16(5)DOI:10.3390/pharmaceutics16050629. PMID:38794292. IF:5.500(Q1/1D).